Outsourcing Potent Drug Contract Manufacturing to Experts

New compounds are becoming increasingly more selective in their pharmacological activity and a trend in drug discovery. Concerning the safe handling of the compounds and achieving dosage repeatability, the production activities involving potent drug contract manufacturing are becoming more challenging.

As a result, lots of businesses opt to outsource contract development and manufacturing organizations (CDMOs) with the required expertise and resources to develop and produce highly potent medications on their behalf.

But if someone wants to contract out the formulation development of a highly potent medicine, what qualities should they seek in a CDMO?

Criteria to consider when selecting a CDMO to develop highly potent formulations

The following criteria should be considered when choosing whether to outsource a potent drug contract manufacturing:

1. Expertise

Finding a good drug content uniformity per unit dose is sometimes the most challenging. Therefore, a component that needs to be considered is the CDMO's history of creating low-dose formulations.

From the initial development of a drug formulation through the clinical process, the personnel in charge of the project should be questioned about their experience and technical expertise.

Also, suitable training protocols must be in place to safely handle potent compounds throughout clinical manufacturing.

2. Capability for processing

Potent drug contract manufacturing formulations frequently include only a few milligrams of medication and occasionally even just a few micrograms. Consideration should be given to the medicine being dissolved in a liquid carrier and put into capsules for shallow dose requirements.

A key factor to consider is if the potential CDMO has the necessary development skills and processing capability to make such low-dose goods.

When outsourcing a formulation development project to a third party, most vendors prefer the CDMO to be responsible for providing products for clinical trial use.

To ensure that the CDMO can scale up operations from benchtop to early-phase cGMP production. In reality, most CDMOs will have a full scale they can create depending on the equipment's capabilities, the facility's adaptability, and the availability of resources. If the project continues to grow, talk with your CDMO about future tech transfer and scale-up alternatives.

3. Project administration

Even if a CDMO appears to have the necessary combination of knowledge, expertise, and processing power, it does not imply that your project will be in good hands.

Project management is one factor that can significantly impact an outsourced development program's success (or failure). Ask the CDMO how projects are routinely accepted, managed, and finished. Also, ask who the project team members will be and your point of contact.

To ensure you are both on the same page, work closely with your CDMO to establish an outline of how the contract partner sees the work program broken down and how each stage will be scheduled. To assist management expectations, decide in advance on the channels, timing, and frequency of communication.

Conclusion

Giving any project to a third-party contractor involves risks, and outsourcing the development of products containing highly potent drugs is precarious. Preferably, your chosen CDMO will not only tick many of the more mechanical selection criteria but also prove an enthusiastic and collaborative attitude to help realize your project goals.

High potency manufacturing is an increasing field with an exclusive set of hurdles. Contact us today to learn more.